 | • レポートコード：20QY06-02992 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒトプロトロンビン複合体のグローバル市場について種類別（500IU/バイアル、600IU/バイアル、1000IU/バイアル、その他）、用途別（血友病B、ビタミンK欠乏症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒトプロトロンビン複合体市場の概要 ・世界の主要地域別ヒトプロトロンビン複合体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒトプロトロンビン複合体市場規模2015-2026：種類別（500IU/バイアル、600IU/バイアル、1000IU/バイアル、その他） ・世界のヒトプロトロンビン複合体市場規模2015-2026：用途別（血友病B、ビタミンK欠乏症、その他） ・ヒトプロトロンビン複合体の北米市場規模2015-2020 ・ヒトプロトロンビン複合体のヨーロッパ市場規模2015-2020 ・ヒトプロトロンビン複合体の中国市場規模2015-2020 ・ヒトプロトロンビン複合体の日本市場規模2015-2020 ・ヒトプロトロンビン複合体の東南アジア市場規模2015-2020 ・ヒトプロトロンビン複合体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Takeda、CSL、Grifols、Octapharma、Hualan Biological、Meheco Xinxing Pharma） ・ヒトプロトロンビン複合体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒトプロトロンビン複合体の市場動向・機会・課題 ・調査の結論 |
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global average price of Human Prothrombin Complex is in the increasing trend, from 124 USD/Unit in 2013 to 137 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Human Prothrombin Complex includes 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial and others, and the proportion of 500 IU/Vial in 2017 is about 51%.
Human Prothrombin Complex is widely used in Hemophilia B, Vitamin K Deficiency and other diseases. The most proportion of Human Prothrombin Complex is Hemophilia B, and the proportion of sales is 48%.
North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%.
Market competition is not intense. Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Human Prothrombin Complex Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Prothrombin Complex market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Prothrombin Complex industry.
Based on our recent survey, we have several different scenarios about the Human Prothrombin Complex YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1260.1 million in 2019. The market size of Human Prothrombin Complex will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Human Prothrombin Complex Scope and Market Size
The global Human Prothrombin Complex market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Prothrombin Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Prothrombin Complex market is segmented into
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application, the Human Prothrombin Complex market is segmented into
Hemophilia B
Vitamin K Deficiency
Others
The Human Prothrombin Complex market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Prothrombin Complex market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Prothrombin Complex Market Share Analysis
Human Prothrombin Complex market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Prothrombin Complex business, the date to enter into the Human Prothrombin Complex market, Human Prothrombin Complex product introduction, recent developments, etc.
The major vendors covered:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
…
1 Human Prothrombin Complex Market Overview
1.1 Human Prothrombin Complex Product Scope
1.2 Human Prothrombin Complex Segment by Type
1.2.1 Global Human Prothrombin Complex Sales by Type (2020-2026)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Segment by Application
1.3.1 Global Human Prothrombin Complex Sales Comparison by Application (2020-2026)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Human Prothrombin Complex Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Prothrombin Complex Sales Growth Rate (2015-2026)
1.4.2 Global Human Prothrombin Complex Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Prothrombin Complex Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Human Prothrombin Complex Industry Impact
1.5.1 How the Covid-19 is Affecting the Human Prothrombin Complex Industry
1.5.1.1 Human Prothrombin Complex Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Human Prothrombin Complex Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Human Prothrombin Complex Players to Combat Covid-19 Impact
2 Human Prothrombin Complex Estimate and Forecast by Region
2.1 Global Human Prothrombin Complex Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Prothrombin Complex Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Prothrombin Complex Sales Market Share by Region (2015-2020)
2.2.2 Global Human Prothrombin Complex Revenue Market Share by Region (2015-2020)
2.3 Global Human Prothrombin Complex Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Prothrombin Complex Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Prothrombin Complex Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Prothrombin Complex Estimates and Projections (2015-2026)
2.4.2 Europe Human Prothrombin Complex Estimates and Projections (2015-2026)
2.4.3 China Human Prothrombin Complex Estimates and Projections (2015-2026)
2.4.4 Japan Human Prothrombin Complex Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Prothrombin Complex Estimates and Projections (2015-2026)
2.4.6 India Human Prothrombin Complex Estimates and Projections (2015-2026)
3 Global Human Prothrombin Complex Competition Landscape by Players
3.1 Global Top Human Prothrombin Complex Players by Sales (2015-2020)
3.2 Global Top Human Prothrombin Complex Players by Revenue (2015-2020)
3.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Prothrombin Complex as of 2019)
3.4 Global Human Prothrombin Complex Average Price by Company (2015-2020)
3.5 Manufacturers Human Prothrombin Complex Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Prothrombin Complex Players (Opinion Leaders)
4 Global Human Prothrombin Complex Market Size by Type
4.1 Global Human Prothrombin Complex Historic Market Review by Type (2015-2020)
4.1.1 Global Human Prothrombin Complex Sales Market Share by Type (2015-2020)
4.1.2 Global Human Prothrombin Complex Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Prothrombin Complex Price by Type (2014-2020)
4.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Prothrombin Complex Sales Forecast by Type (2021-2026)
4.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Prothrombin Complex Price Forecast by Type (2021-2026)
5 Global Human Prothrombin Complex Market Size by Application
5.1 Global Human Prothrombin Complex Historic Market Review by Application (2015-2020)
5.1.1 Global Human Prothrombin Complex Sales Market Share by Application (2015-2020)
5.1.2 Global Human Prothrombin Complex Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Prothrombin Complex Price by Application (2015-2020)
5.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Prothrombin Complex Sales Forecast by Application (2021-2026)
5.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Prothrombin Complex Price Forecast by Application (2021-2026)
3 North America Human Prothrombin Complex Market Facts & Figures
3.2 North America Human Prothrombin Complex Sales Market Share by Company (2015-2020)
3.3 North America Human Prothrombin Complex Sales Market Share by Type (2015-2020)
3.4 North America Human Prothrombin Complex Sales Market Share by Application (2015-2020)
4 Europe Human Prothrombin Complex Market Facts & Figures
4.2 Europe Human Prothrombin Complex Sales Market Share by Company (2015-2020)
4.3 Europe Human Prothrombin Complex Sales Market Share by Type (2015-2020)
4.4 Europe Human Prothrombin Complex Sales Market Share by Application (2015-2020)
5 China Human Prothrombin Complex Market Facts & Figures
5.2 China Human Prothrombin Complex Sales Market Share by Company (2015-2020)
5.3 China Human Prothrombin Complex Sales Market Share by Type (2015-2020)
5.4 China Human Prothrombin Complex Sales Market Share by Application (2015-2020)
6 Japan Human Prothrombin Complex Market Facts & Figures
6.2 Japan Human Prothrombin Complex Sales Market Share by Company (2015-2020)
6.3 Japan Human Prothrombin Complex Sales Market Share by Type (2015-2020)
6.4 Japan Human Prothrombin Complex Sales Market Share by Application (2015-2020)
7 Southeast Asia Human Prothrombin Complex Market Facts & Figures
7.2 Southeast Asia Human Prothrombin Complex Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Human Prothrombin Complex Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Human Prothrombin Complex Sales Market Share by Application (2015-2020)
8 India Human Prothrombin Complex Market Facts & Figures
8.2 India Human Prothrombin Complex Sales Market Share by Company (2015-2020)
8.3 India Human Prothrombin Complex Sales Market Share by Type (2015-2020)
8.4 India Human Prothrombin Complex Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Prothrombin Complex Business
12.1 Takeda
12.1.1 Takeda Human Prothrombin Complex Corporation Information
12.1.2 Takeda Human Prothrombin Complex Business Overview and Total Revenue
12.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Takeda Human Prothrombin Complex Products Offered
12.1.5 Takeda Recent Development
12.2 CSL
12.2.1 CSL Human Prothrombin Complex Corporation Information
12.2.2 CSL Human Prothrombin Complex Business Overview and Total Revenue
12.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Human Prothrombin Complex Products Offered
12.2.5 CSL Recent Development
12.3 Grifols
12.3.1 Grifols Human Prothrombin Complex Corporation Information
12.3.2 Grifols Human Prothrombin Complex Business Overview and Total Revenue
12.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Grifols Human Prothrombin Complex Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Human Prothrombin Complex Corporation Information
12.4.2 Octapharma Human Prothrombin Complex Business Overview and Total Revenue
12.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma Human Prothrombin Complex Products Offered
12.4.5 Octapharma Recent Development
12.5 Hualan Biological
12.5.1 Hualan Biological Human Prothrombin Complex Corporation Information
12.5.2 Hualan Biological Human Prothrombin Complex Business Overview and Total Revenue
12.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hualan Biological Human Prothrombin Complex Products Offered
12.5.5 Hualan Biological Recent Development
12.6 Meheco Xinxing Pharma
12.6.1 Meheco Xinxing Pharma Human Prothrombin Complex Corporation Information
12.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Business Overview and Total Revenue
12.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
12.6.5 Meheco Xinxing Pharma Recent Development
…
13 Human Prothrombin Complex Manufacturing Cost Analysis
13.1 Human Prothrombin Complex Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Prothrombin Complex
13.4 Human Prothrombin Complex Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Prothrombin Complex Distributors List
14.3 Human Prothrombin Complex Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Prothrombin Complex Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Human Prothrombin Complex Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Human Prothrombin Complex Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Human Prothrombin Complex Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Human Prothrombin Complex Players to Combat Covid-19 Impact
Table 8. Global Market Human Prothrombin Complex Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Human Prothrombin Complex Sales (MT) by Region (2015-2020)
Table 10. Global Human Prothrombin Complex Sales Market Share by Region (2015-2020)
Table 11. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Human Prothrombin Complex Revenue Share by Region (2015-2020)
Table 13. Global Human Prothrombin Complex Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Human Prothrombin Complex Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Human Prothrombin Complex Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Human Prothrombin Complex Revenue Share Forecast by Region (2021-2026)
Table 17. Global Human Prothrombin Complex (MT) of Key Companies (2015-2020)
Table 18. Global Human Prothrombin Complex Sales Share by Company (2015-2020)
Table 19. Global Human Prothrombin Complex Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Human Prothrombin Complex Revenue Share by Company (2015-2020)
Table 21. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Prothrombin Complex as of 2019)
Table 22. Global Human Prothrombin Complex Average Price (K USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Human Prothrombin Complex Manufacturing Sites and Area Served
Table 24. Manufacturers Human Prothrombin Complex Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Human Prothrombin Complex Players
Table 27. Global Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 28. Global Human Prothrombin Complex Sales Share by Type (2015-2020)
Table 29. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Human Prothrombin Complex Price (MT) by Type (2015-2020)
Table 31. Global Human Prothrombin Complex Sales Share by Type (2021-2026)
Table 32. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Human Prothrombin Complex Revenue Share by Type (2021-2026)
Table 34. Global Human Prothrombin Complex Price (MT) by Type (2021-2026)
Table 35. Global Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 36. Global Human Prothrombin Complex Sales Share by Application (2015-2020)
Table 37. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Human Prothrombin Complex Price (MT) by Application (2015-2020)
Table 39. Global Human Prothrombin Complex Sales (MT) by Application (2021-2026)
Table 40. Global Human Prothrombin Complex Sales Share by Application (2021-2026)
Table 41. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Human Prothrombin Complex Revenue Share by Application (2021-2026)
Table 43. Global Human Prothrombin Complex Price (MT) by Application (2021-2026)
Table 44. United States Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 45. United States Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 46. United States Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 47. United States Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 48. United States Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 49. United States Human Prothrombin Complex Sales Market Share by Application (2015-2020)
Table 50. Europe Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 51. Europe Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 52. Europe Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 53. Europe Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 54. Europe Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 55. Europe Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 56. China Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 57. China Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 58. China Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 59. China Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 60. China Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 61. China Human Prothrombin Complex Sales Market Share by Application (2015-2020)
Table 62. Japan Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 63. Japan Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 64. Japan Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 65. Japan Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 66. Japan Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 67. Japan Human Prothrombin Complex Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Human Prothrombin Complex Sales Market Share by Application (2015-2020)
Table 74. India Human Prothrombin Complex Sales (MT) by Company (2015-2020)
Table 75. India Human Prothrombin Complex Sales Market Share by Company (2015-2020)
Table 76. India Human Prothrombin Complex Sales (MT) by Type (2015-2020)
Table 77. India Human Prothrombin Complex Sales Market Share by Type (2015-2020)
Table 78. India Human Prothrombin Complex Sales (MT) by Application (2015-2020)
Table 79. India Human Prothrombin Complex Sales Market Share by Application (2015-2020)
Table 80. Takeda Corporation Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 83. Takeda Human Prothrombin Complex Product
Table 84. Takeda Recent Development
Table 85. CSL Corporation Information
Table 86. CSL Description and Business Overview
Table 87. CSL Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 88. CSL Human Prothrombin Complex Product
Table 89. CSL Recent Development
Table 90. Grifols Corporation Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 93. Grifols Human Prothrombin Complex Product
Table 94. Grifols Recent Development
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 98. Octapharma Human Prothrombin Complex Product
Table 99. Octapharma Recent Development
Table 100. Hualan Biological Corporation Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 103. Hualan Biological Human Prothrombin Complex Product
Table 104. Hualan Biological Recent Development
Table . Meheco Xinxing Pharma Corporation Information
Table . Meheco Xinxing Pharma Description and Business Overview
Table . Meheco Xinxing Pharma Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table . Meheco Xinxing Pharma Human Prothrombin Complex Product
Table . Meheco Xinxing Pharma Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Human Prothrombin Complex Distributors List
Table 113. Human Prothrombin Complex Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Prothrombin Complex Market Share by Application in 2020 & 2026
Figure 6. Hemophilia B Examples
Figure 7. Vitamin K Deficiency Examples
Figure 8. Others Examples
Figure 9. Global Human Prothrombin Complex Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Human Prothrombin Complex Price Trends Growth Rate (2015-2026) (K USD/MT)
Figure 12. Global Human Prothrombin Complex Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Human Prothrombin Complex Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Human Prothrombin Complex Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Human Prothrombin Complex Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Human Prothrombin Complex Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Human Prothrombin Complex Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Human Prothrombin Complex Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Prothrombin Complex Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Human Prothrombin Complex Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Human Prothrombin Complex Players Market Share by Revenue in Human Prothrombin Complex 2015 & 2019
Figure 27. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Human Prothrombin Complex Revenue Share by Type (2015-2020)
Figure 29. Global Human Prothrombin Complex Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Human Prothrombin Complex Revenue Share by Application (2015-2020)
Figure 31. Global Human Prothrombin Complex Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 33. United States Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 34. Europe Human Prothrombin Complex Sales Market Share by Company in 2019
Figure 35. Europe Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 36. Europe Human Prothrombin Complex Sales Market Share by Application in 2019
Figure 37. China Human Prothrombin Complex Sales Market Share by Company in 2019
Figure 38. China Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 39. China Human Prothrombin Complex Sales Market Share by Application in 2019
Figure 40. Japan Human Prothrombin Complex Sales Market Share by Company in 2019
Figure 41. Japan Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 42. Japan Human Prothrombin Complex Sales Market Share by Application in 2019
Figure 43. Southeast Asia Human Prothrombin Complex Sales Market Share by Company in 2019
Figure 44. Southeast Asia Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 45. Southeast Asia Human Prothrombin Complex Sales Market Share by Application in 2019
Figure 46. India Human Prothrombin Complex Sales Market Share by Company in 2019
Figure 47. India Human Prothrombin Complex Sales Market Share by Type in 2019
Figure 48. India Human Prothrombin Complex Sales Market Share by Application in 2019
Figure 49. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Hualan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Meheco Xinxing Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Human Prothrombin Complex
Figure 57. Manufacturing Process Analysis of Human Prothrombin Complex
Figure 58. Human Prothrombin Complex Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
プロトロンビン複合体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prothrombin Complex market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prothrombin Complex marke…- 複合キャブレターの世界市場レポート2020 Market Analysis and Insights: Global Complex Carburetor Market The global Complex Carburetor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Complex Carburetor Scope and Market Size The global Complex Car…
- 複合プログラマブルロジックデバイスの世界市場レポート2020 Market Analysis and Insights: Global Complex Programmable Logic Devices Market The global Complex Programmable Logic Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Complex Programmable Logic Devi…
- 複雑プログラマブルロジックデバイス（CPLD）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Complex Programmable Logic Devices (CPLD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Com…
- 複雑経皮的冠動脈インターベンションの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Complex Percutaneous Coronary Intervention market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Co…